Search This Blog

Thursday, July 11, 2019

FDA OKs Abbott’s Alinity

The FDA approves Abbott’s (ABT -0.2%) Alinity system for screening blood and plasma. The company says the instrument can process up to 600 tests per hour while requiring less space than other systems in its class.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.